Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
Minority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequitie...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.023852 |
_version_ | 1797945380319526912 |
---|---|
author | Rachel E. Ohman Eric H. Yang Melissa L. Abel |
author_facet | Rachel E. Ohman Eric H. Yang Melissa L. Abel |
author_sort | Rachel E. Ohman |
collection | DOAJ |
description | Minority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequities in the growing vulnerable population of patients with cancer and cardiovascular disease. This review identifies 13 cohort studies and 2 meta‐analyses investigating disparate outcomes in treatment‐associated cardiotoxicity and situates these data within the context of oncologic disparities, preexisting cardiovascular disparities, and potential system‐level inequities. Black survivors of breast cancer have elevated risks of cardiotoxicity morbidity and mortality compared with White counterparts. Adolescent and young adult survivors of cancer with lower socioeconomic status experience worsened cardiovascular outcomes compared with those of higher socioeconomic status. Female patients treated with anthracyclines or radiation have higher risks of cardiotoxicity compared with male patients. Given the paucity of data, our understanding of these racial and ethnic, socioeconomic, and sex and gender disparities remains limited and large‐scale studies are needed for elucidation. Prioritizing this research while addressing clinical trial inclusion and access to specialist care is paramount to reducing health inequity. |
first_indexed | 2024-04-10T20:54:14Z |
format | Article |
id | doaj.art-1a77dd8a481142bbbe3993a1867ecacb |
institution | Directory Open Access Journal |
issn | 2047-9980 |
language | English |
last_indexed | 2024-04-10T20:54:14Z |
publishDate | 2021-12-01 |
publisher | Wiley |
record_format | Article |
series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
spelling | doaj.art-1a77dd8a481142bbbe3993a1867ecacb2023-01-23T07:23:59ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-12-01102410.1161/JAHA.121.023852Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer OutcomesRachel E. Ohman0Eric H. Yang1Melissa L. Abel2Department of Medicine University of California Los Angeles Los Angeles CAUCLA Cardio‐Oncology Program Division of Cardiology Department of Medicine University of California at Los Angeles CACenter for Cancer Research National Cancer Institute Bethesda MDMinority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequities in the growing vulnerable population of patients with cancer and cardiovascular disease. This review identifies 13 cohort studies and 2 meta‐analyses investigating disparate outcomes in treatment‐associated cardiotoxicity and situates these data within the context of oncologic disparities, preexisting cardiovascular disparities, and potential system‐level inequities. Black survivors of breast cancer have elevated risks of cardiotoxicity morbidity and mortality compared with White counterparts. Adolescent and young adult survivors of cancer with lower socioeconomic status experience worsened cardiovascular outcomes compared with those of higher socioeconomic status. Female patients treated with anthracyclines or radiation have higher risks of cardiotoxicity compared with male patients. Given the paucity of data, our understanding of these racial and ethnic, socioeconomic, and sex and gender disparities remains limited and large‐scale studies are needed for elucidation. Prioritizing this research while addressing clinical trial inclusion and access to specialist care is paramount to reducing health inequity.https://www.ahajournals.org/doi/10.1161/JAHA.121.023852cardiotoxicitycardio‐oncologydisparitiessocial determinants of health |
spellingShingle | Rachel E. Ohman Eric H. Yang Melissa L. Abel Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease cardiotoxicity cardio‐oncology disparities social determinants of health |
title | Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes |
title_full | Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes |
title_fullStr | Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes |
title_full_unstemmed | Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes |
title_short | Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes |
title_sort | inequity in cardio oncology identifying disparities in cardiotoxicity and links to cardiac and cancer outcomes |
topic | cardiotoxicity cardio‐oncology disparities social determinants of health |
url | https://www.ahajournals.org/doi/10.1161/JAHA.121.023852 |
work_keys_str_mv | AT racheleohman inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes AT erichyang inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes AT melissalabel inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes |